• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过溴脱氧尿苷(BUdR)和Ki-67标记指数以及肿瘤倍增时间评估复发性颅内脑膜瘤的增殖潜能。

Proliferative potential of recurrent intracranial meningiomas as evaluated by labelling indices of BUdR and Ki-67, and tumour doubling time.

作者信息

Kakinuma K, Tanaka R, Onda K, Takahashi H

机构信息

Department of Neurosurgery, Niigata University, Japan.

出版信息

Acta Neurochir (Wien). 1998;140(1):26-31; discussion 31-2. doi: 10.1007/s007010050053.

DOI:10.1007/s007010050053
PMID:9522904
Abstract

This study was designed to provide the reciprocal relationship among labelling indices of 5-bromodeoxyuridine (BUdR LI), Ki-67 (Ki-LI), and tumour doubling time (Td) of recurrent meningiomas. In our series of 182 primary intracranial meningiomas, 46 cases recurred. The average of BUdR LI and Ki LI for nonrecurrent meningiomas were 0.77 +/- 0.13% and 4.71 +/- 1.96%, respectively. Recurrent meningiomas had significantly higher LIs at the first operation: BUdR LI was 3.77 +/- 1.22% and Ki LI was 14.78 +/- 3.17%. The recurrent ratio significantly increased with the degrees of each LI. And the linear regression analysis has demonstrated a significant correlation between BUdR and Ki LI. Td was calculated accurately by NIH, a computer software. Td showed a significant inverse correlation with each of the labelling indices. Consequently, BUdR, Ki LIs and Td of individual tumours correlate mutually well. Of the 46 recurrent cases, 4 received radiation after the operation. Td of the irradiated meningiomas tended to be longer than expected for their higher level of BUdR and Ki LIs before radiation therapy. Thus, it was shown that the radiation therapy delays the regrowth of meningiomas.

摘要

本研究旨在探讨复发性脑膜瘤中5-溴脱氧尿苷标记指数(BUdR LI)、Ki-67(Ki-LI)与肿瘤倍增时间(Td)之间的相互关系。在我们的182例原发性颅内脑膜瘤系列中,有46例复发。非复发性脑膜瘤的BUdR LI和Ki LI平均值分别为0.77±0.13%和4.71±1.96%。复发性脑膜瘤在首次手术时的LI显著更高:BUdR LI为3.77±1.22%,Ki LI为14.78±3.17%。复发率随各LI程度显著增加。线性回归分析表明BUdR与Ki LI之间存在显著相关性。Td通过计算机软件NIH准确计算。Td与各标记指数均呈显著负相关。因此,单个肿瘤的BUdR、Ki LIs和Td相互之间相关性良好。在46例复发病例中,4例术后接受了放疗。放疗后脑膜瘤的Td往往比放疗前其较高水平的BUdR和Ki LIs所预期的要长。因此,表明放疗会延迟脑膜瘤的再生长。

相似文献

1
Proliferative potential of recurrent intracranial meningiomas as evaluated by labelling indices of BUdR and Ki-67, and tumour doubling time.通过溴脱氧尿苷(BUdR)和Ki-67标记指数以及肿瘤倍增时间评估复发性颅内脑膜瘤的增殖潜能。
Acta Neurochir (Wien). 1998;140(1):26-31; discussion 31-2. doi: 10.1007/s007010050053.
2
Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling.
Neurosurgery. 1992 Apr;30(4):494-7; discussion 497-8. doi: 10.1227/00006123-199204000-00004.
3
Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.儿童颅内脑膜瘤:一项包括MIB-1免疫组织化学的临床病理研究
Pathol Res Pract. 2000;196(3):151-8. doi: 10.1016/S0344-0338(00)80095-3.
4
Prediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labeling.
J Neurosurg. 1986 Dec;65(6):790-4. doi: 10.3171/jns.1986.65.6.0790.
5
PCNA, Ki-67 and hTERT in residual benign meningiomas.残留良性脑膜瘤中的增殖细胞核抗原、Ki-67和人端粒酶逆转录酶
In Vivo. 2006 Mar-Apr;20(2):271-5.
6
Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas.复发性和非复发性脑膜瘤的组织病理学特征及MIB-1标记指数
Arch Pathol Lab Med. 1999 Sep;123(9):793-800. doi: 10.5858/1999-123-0793-HFAMLI.
7
The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.脑膜瘤中的Ki-67增殖抗原。600例病例的经验。
Acta Neurochir (Wien). 2004 Jan;146(1):37-44; discussion 44. doi: 10.1007/s00701-003-0173-4. Epub 2003 Dec 22.
8
Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.检测脑膜瘤中的孕激素受体与 Ki-67 标记指数的相关性。
Neurol India. 2011 Nov-Dec;59(6):817-22. doi: 10.4103/0028-3886.91357.
9
DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.脑膜瘤中DNA拓扑异构酶II-α和细胞周期蛋白A的免疫表达及其预后意义:263例分析
Arch Pathol Lab Med. 2002 Sep;126(9):1079-86. doi: 10.5858/2002-126-1079-DTIACA.
10
Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination.
Acta Neurochir (Wien). 1986;81(3-4):135-41. doi: 10.1007/BF01401236.

引用本文的文献

1
(99m)Tc-Tetrofosmin brain SPECT in the assessment of meningiomas-correlation with histological grade and proliferation index.(99m)锝-替曲膦脑单光子发射计算机断层扫描在脑膜瘤评估中与组织学分级及增殖指数的相关性
J Neurooncol. 2008 Sep;89(2):225-30. doi: 10.1007/s11060-008-9611-8. Epub 2008 May 6.
2
Clinical and radiological features related to the growth potential of meningioma.与脑膜瘤生长潜能相关的临床和影像学特征
Neurosurg Rev. 2006 Oct;29(4):293-6; discussion 296-7. doi: 10.1007/s10143-006-0039-3. Epub 2006 Sep 5.